GLOBAL NEUROREHABILITATION DEVICE MARKET FORECAST 2021-2028

The global neurorehabilitation device market is projected to register a CAGR of 15.12% and is anticipated to generate revenue of $ 4035.7 million by 2028. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2028.

Neurorehabilitation is a crucial part of the recovery process of patients who have sustained a brain injury. Neurological disorders include tetanus, meningitis, encephalitis, stroke, Alzheimer’s disease, and other dementias, Parkinson’s disease, epilepsy, multiple sclerosis, and migraine, among others.

europe-neurorehabilitation-device-market

To learn more about this report, request a free sample copy

Key factors propelling the global neurorehabilitation device market growth:

  • Growing elderly populace
  • Increasing neurorehabilitation wearables and robotics
    • Rehabilitation robotics includes the development of robotic devices, personalized for assisting various sensorimotor functions such as arm, hand, leg, and ankle.
    • Due to the growing emergence of wearables and robotics, companies are mainly focusing on their development, especially for neurorehabilitation devices.
  • Significant rise in neurological diseases
  • Technological advancements

Major restraining factors:

  • Dearth of skilled specialists
  • High cost of treatment
    • According to the Journal of Novel Physiotherapies (Omics International, Open Access Journals), Functional Electrical Stimulation (FES) is one of the leading therapies offered for neurorehabilitation.
    • However, it has a high cost of treatment, due to the regular replacement of surface electrodes, in order to maintain a good quality of devices.
  • Stringent regulations

The report scope of the global neurorehabilitation device market includes segmentation analysis based on product, application, and end-user. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Stroke
    • The stroke segment dominated the application category in 2020.
    • Some of the neurorehabilitation devices used for patients with stroke, include robotic devices for upper and lower limb recovery, non-invasive brain simulators, neuroprosthetics, and brain-computer interfaces.
  • Parkinson’s Disease
    • The Parkinson’s disease segment, in terms of the application category, is set to grow with the highest CAGR.
    • Presently, a treatment for Parkinson’s disease does not exist. Nevertheless, neurorehabilitation programs and services help patients with Parkinson’s disease to an extent, in order to improve and maintain routine activities.

Geographically, the global neurorehabilitation device market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America is set to dominate the global market.
    • The region’s market is mainly driven by the growing geriatric populace, resulting in the high incidence of Alzheimer’s and Parkinson’s disease, the investments made for diagnosing and preventing neurodegenerative diseases, federal governments’ funding, and the initiatives introduced by the Senate of Canada.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia Pacific: India, Australia & New Zealand, China, South Korea, Japan, Thailand, Indonesia, Vietnam, and Rest of Asia Pacific
    • The Asia Pacific is projected to be the fastest-growing market, over the forecast period.
    • The China neurorehabilitation device market is primarily driven by the continually rising population, which impacts the prevalence of the aging population as well as the rising incidence of dementia, mainly across the country’s semi-urban and rural provinces.
    • Moreover, Japan’s neurorehabilitation device market is primarily fueled by private organizations’ investments, rising neurological diseases, and the increased geriatric populace.
  • Rest of World: Latin America, the Middle East & Africa

The major market players in the global neurorehabilitation device market: 

  • Abbott Laboratories
  • Ekso Bionics Holdings Inc
  • Helius Medical Technologies
  • Hocoma AG
  • Medtronic Inc
  • Others

Key strategies adopted by some of these companies:

In March 2020, BioXtreme and Heliomare announced their agreement to conduct a joint clinical trial research project in the Heliomare facility, the Netherlands. BioXtreme developed a ground-breaking technology that reduces the recovery time for the upper limb, from stroke and other neurological injuries, by up to 50%.

Key findings of the global neurorehabilitation device market:

  • The neuro-robotic system holds the largest market share, in terms of the product category.
  • Stroke is set to be the dominating application.
  • The prevalence of neurological disorders, especially across developing economies, is substantially increasing.
  • The growing number of neurological diseases are set to fuel market growth.

 

Frequently Asked Questions & Answers (FAQs):

  • How has the COVID-19 pandemic impacted the global neurorehabilitation device market growth?

A: On account of the COVID-19 pandemic, neurorehabilitation centers are suspended, in order to avoid close contact for preventing the virus’ spread. As a result, neurorehabilitation services have also been halted. Besides, rehabilitation centers are only limited to individuals with severe post-acute disabilities.

  • What is the role of the elderly population in the neurorehabilitation device market?

A: Neurological disorders such as strokes, neuropathy, Alzheimer’s, etc., are highly prevalent among the elderly population (over 65 years of age). These diseases preferentially affect the central nervous system, thereby promoting the market growth.

  • How do neurorehabilitation wearables assist people suffering from neurological disorders?

A: Neurorehabilitation wearables assist patients suffering from neurological disorders, as well as researchers and medical professionals, by accurately tracking the patient’s movement.

On account of the COVID-19 pandemic, neurorehabilitation centers are suspended, in order to avoid close contact for preventing the virus’ spread. As a result, neurorehabilitation services have also been halted. Besides, rehabilitation centers are only limited to individuals with severe post-acute disabilities.
Neurological disorders such as strokes, neuropathy, Alzheimer’s, etc., are highly prevalent among the elderly population (over 65 years of age). These diseases preferentially affect the central nervous system, thereby promoting the market growth.
Neurorehabilitation wearables assist patients suffering from neurological disorders, as well as researchers and medical professionals, by accurately tracking the patient’s movement.
TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. GROWING ELDERLY POPULACE
      2. GROWING NEUROREHABILITATION WEARABLES AND ROBOTICS
      3. SIGNIFICANT RISE IN NEUROLOGICAL DISEASES
      4. TECHNOLOGICAL ADVANCEMENTS
    2. KEY RESTRAINTS
      1. DEARTH OF SKILLED SPECIALISTS
      2. HIGH COST OF TREATMENT
      3. STRINGENT REGULATIONS
  4. KEY ANALYTICALS
    1. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRANTS
      2. THREAT OF SUBSTITUTES
      3. BARGAINING POWER OF BUYER
      4. BARGAINING POWER OF SUPPLIER
      5. INTENSITY OF COMPETITIVE RIVALRY
    2. IMPACT OF COVID-19 ON NEUROREHABILITATION DEVICE MARKET
    3. SUPPLY CHAIN ANALYSIS
    4. TIMELINE OF NEUROREHABILITATION DEVICE
    5. KEY BUYING CRITERIA
    6. OPPORTUNITY MATRIX
    7. VENDOR LANDSCAPE
    8. KEY INVESTMENT INSIGHTS
  5. MARKET BY PRODUCT
    1. NEURO-ROBOTIC SYSTEM
    2. BRAIN COMPUTER INTERFACE
    3. WEARABLE DEVICE
    4. NON-INVASIVE STIMULATOR
    5. OTHER PRODUCTS
  6. MARKET BY APPLICATION
    1. STROKE
    2. CEREBRAL PALSY
    3. PARKINSON’S DISEASE
    4. MULTIPLE SCLEROSIS
    5. OTHER APPLICATIONS
  7. MARKET BY END-USER
    1. HOSPITAL/CLINIC
    2. RESEARCH INSTITUTE
    3. COGNITIVE CARE CENTER
    4. OTHER END-USERS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. GERMANY
        2. FRANCE
        3. UNITED KINGDOM
        4. ITALY
        5. RUSSIA
        6. BELGIUM
        7. POLAND
        8. REST OF EUROPE
    3. ASIA PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. AUSTRALIA & NEW ZEALAND
        4. INDIA
        5. SOUTH KOREA
        6. THAILAND
        7. INDONESIA
        8. VIETNAM
        9. REST OF ASIA PACIFIC
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
        2. MIDDLE EAST & AFRICA
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGER & ACQUISITIONS
      2. PRODUCT LAUNCH & DEVELOPMENTS
      3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
      4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
      2. BIOMETRICS LTD
      3. BIONIK LABORATORIES CORP
      4. BIOXTREME
      5. ECTRON LIMITED
      6. EKSO BIONICS HOLDINGS INC
      7. HELIUS MEDICAL TECHNOLOGIES
      8. HOCOMA AG
      9. KINESTICA
      10. KINOVA
      11. MEDTRONIC INC
      12. NEUROSTYLE PTE LTD
      13. TYROMOTION GMBH     
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – NEUROREHABILITATION DEVICE

TABLE 2: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 3: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 4: GLOBAL NEURO-ROBOTIC SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 5: GLOBAL NEURO-ROBOTIC SYSTEM MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 6: GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 7: GLOBAL BRAIN COMPUTER INTERFACE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 8: GLOBAL WEARABLE DEVICE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 9: GLOBAL WEARABLE DEVICE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 10: GLOBAL NON-INVASIVE STIMULATOR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 11: GLOBAL NON-INVASIVE STIMULATOR MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 12: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 13: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 14: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 15: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 16: GLOBAL STROKE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 17: GLOBAL STROKE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 18: GLOBAL CEREBRAL PALSY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 19: GLOBAL CEREBRAL PALSY MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 20: GLOBAL PARKINSON’S DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 21: GLOBAL PARKINSON’S DISEASE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 22: GLOBAL MULTIPLE SCLEROSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 23: GLOBAL MULTIPLE SCLEROSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 24: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 25: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 26: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 27: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END-USER, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 28: GLOBAL HOSPITALS/CLINIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 29: GLOBAL HOSPITALS/CLINIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 30: GLOBAL RESEARCH INSTITUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 31: GLOBAL RESEARCH INSTITUTE MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 32: GLOBAL COGNITIVE CARE CENTER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 33: GLOBAL COGNITIVE CARE CENTER MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 34: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 35: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 36: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 ($ MILLION)

TABLE 37: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 ($ MILLION)

TABLE 38: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: LEADING PLAYERS OPERATING IN NORTH AMERICA NEUROREHABILITATION DEVICE MARKET

TABLE 41: EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 42: EUROPE NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 43: LEADING PLAYERS OPERATING IN EUROPE NEUROREHABILITATION DEVICE MARKET

TABLE 44: ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 45: ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 46: LEADING PLAYERS OPERATING IN ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET

TABLE 47: REST OF WORLD NEUROREHABILITATION DEVICE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 48: REST OF WORLD NEUROREHABILITATION DEVICE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 49: LEADING PLAYERS OPERATING IN REST OF WORLD NEUROREHABILITATION DEVICE MARKET

LIST OF FIGURES

FIGURE 1: PREVALENCE OF ALZHEIMER’S DISEASE IN THE UNITED STATES, AGE WISE, 2019 (%)

FIGURE 2: NUMBER OF ELDERLY POPULACE, BY GEOGRAPHY (IN MILLION)

FIGURE 3: INCREASE IN THE PREVALENCE OF PARKINSON’S DISEASE GLOBALLY (IN MILLION)

FIGURE 4: PORTER’S FIVE FORCE ANALYSIS

FIGURE 5: TIMELINE OF NEUROREHABILITATION DEVICE MARKET

FIGURE 6: OPPORTUNITY MATRIX

FIGURE 7: VENDOR LANDSCAPE

FIGURE 8: KEY INVESTMENT INSIGHTS

FIGURE 9: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, IN 2020

FIGURE 10: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY NEURO-ROBOTIC SYSTEM, 2021-2028 ($ MILLION)

FIGURE 11: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY BRAIN COMPUTER INTERFACE, 2021-2028 ($ MILLION)

FIGURE 12: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY WEARABLE DEVICE, 2021-2028 ($ MILLION)

FIGURE 13: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY NON-INVASIVE STIMULATOR, 2021-2028 ($ MILLION)

FIGURE 14: GLOBAL NEUROREHABILITATION DEVICE MARKET BY, OTHER PRODUCTS, 2021-2028 ($ MILLION)

FIGURE 15: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, IN 2020

FIGURE 16: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY STROKE, 2021-2028 ($ MILLION)

FIGURE 17: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY CEREBRAL PALSY, 2021-2028 ($ MILLION)

FIGURE 18: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY PARKINSON’S DISEASE, 2021-2028 ($ MILLION)

FIGURE 19: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY MULTIPLE SCLEROSIS, 2021-2028 ($ MILLION)

FIGURE 20: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY OTHER APPLICATIONS, 2021-2028 ($ MILLION)

FIGURE 21: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END-USER, IN 2020

FIGURE 22: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY HOSPITAL/CLINIC, 2021-2028 ($ MILLION)

FIGURE 23: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY RESEARCH INSTITUTE, 2021-2028 ($ MILLION)

FIGURE 24: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY COGNITIVE CARE CENTER, 2021-2028 ($ MILLION)

FIGURE 25: GLOBAL NEUROREHABILITATION DEVICE MARKET, BY OTHER END-USERS, 2021-2028 ($ MILLION)

FIGURE 26: NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: UNITED STATES NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 28: CANADA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 29: EUROPE NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 30: GERMANY NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 31: FRANCE NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 32: UNITED KINGDOM NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 33: ITALY NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: RUSSIA NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: BELGIUM NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: POLAND NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: REST OF EUROPE NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 38: ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 39: CHINA NEURO REHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 40: JAPAN NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 41: AUSTRALIA & NEW ZEALAND NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 42: INDIA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 43: SOUTH KOREA NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: THAILAND NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 45: INDONESIA NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: VIETNAM NEUROREHABILITATION DEVICE MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: REST OF ASIA PACIFIC NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 48: REST OF WORLD NEUROREHABILITATION DEVICE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 49: LATIN AMERICA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

FIGURE 50: MIDDLE EAST & AFRICA NEUROREHABILITATION DEVICE MARKET, 2021-2028 ($ MILLION)

Request For A Free Sample